News

Leftist’s Flop in Colombia Sparks Wild Election-Bet Stock Rally

(Bloomberg) -- It’s been an unusual start to the year for Colombian stocks.Most Read from BloombergWhy Barcelona Bought the Building That Symbolizes Its Housing CrisisPor qué Barcelona compró el edificio que simboliza su crisis inmobiliariaA Filmmaker’s Surreal Journey Into His Own Private WinnipegTrump Child Refugee Agency Shares Data With Immigration EnforcersNYC Restaurants Are Still Waiting for Their Outdoor Dining Plans to Be ApprovedFor one, the market is way up — some 21% in dollar terms,

Hillman (NASDAQ:HLMN) Misses Q4 Sales Targets

Hardware products and merchandising solutions provider Hillman (NASDAQ:HLMN) missed Wall Street’s revenue expectations in Q4 CY2024, with sales flat year on year at $349.6 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.54 billion at the midpoint. Its non-GAAP profit of $0.10 per share was in line with analysts’ consensus estimates.

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 10.6% year on year to $172 million. On the other hand, the company’s full-year revenue guidance of $740 million at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.04 per share was $0.01 above analysts’ consensus estimates.